Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lipogelosomes: a novel approach to lowering cholesterol

Oct. 16, 1997

Preclinical cholesterol-lowering efficacy described for FR-194738

Oct. 16, 1997

Fujisawa's benzimidazole derivatives have broad therapeutic potential

Oct. 15, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

Yamanouchi files for approval of hypoglycemic agent

Oct. 15, 1997

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

Bristol-Myers Squibb and Karo Bio to codevelop new therapies for metabolic disorders

Oct. 15, 1997

Nonthiazolidinediones for diabetes and obesity described by Merck & Co.

Oct. 14, 1997

Heterocyclic compounds from Zeneca for hypercholesterolemia

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...